Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1977-7-29
|
pubmed:abstractText |
1. Five patients with the osteomalacia of chronic renal failure were given 50--100 nmol of 25-hydroxy vitamin D3 intravenously per day for 24--28 days. 2. In all five patients, during administration of 25-hydroxy vitamin D3 there was a substantial rise in the plasma concentration of 25-hydroxy vitamin D from initially abnormally low values. 3. Significant improvement in bone mineralization, intestinal calcium absorption and muscle strength occurred in the three patients with the greatest rise in plasma 25-hydroxy vitamin D.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0301-0538
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
499-508
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:862343-Aged,
pubmed-meshheading:862343-Calcification, Physiologic,
pubmed-meshheading:862343-Calcium,
pubmed-meshheading:862343-Female,
pubmed-meshheading:862343-Humans,
pubmed-meshheading:862343-Hydroxycholecalciferols,
pubmed-meshheading:862343-Kidney Failure, Chronic,
pubmed-meshheading:862343-Male,
pubmed-meshheading:862343-Middle Aged,
pubmed-meshheading:862343-Osteomalacia,
pubmed-meshheading:862343-Phosphorus
|
pubmed:year |
1977
|
pubmed:articleTitle |
The effect of 25-hydroxy vitamin D3 in the osteomalacia of chronic renal failure.
|
pubmed:publicationType |
Journal Article
|